BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3057381)

  • 1. Proteolytic fragment or new gene product?
    Hoffman EP; Kunkel LM; Brown RH
    Nature; 1988 Nov; 336(6196):210. PubMed ID: 3057381
    [No Abstract]   [Full Text] [Related]  

  • 2. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle.
    Zubrzycka-Gaarn EE; Bulman DE; Karpati G; Burghes AH; Belfall B; Klamut HJ; Talbot J; Hodges RS; Ray PN; Worton RG
    Nature; 1988 Jun; 333(6172):466-9. PubMed ID: 3287171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is nebulin the defective gene product in Duchenne muscular dystrophy?
    Wood DS; Zeviani M; Prelle A; Bonilla E; Salviati G; Miranda AF; DiMauro S; Rowland LP
    N Engl J Med; 1987 Jan; 316(2):107-8. PubMed ID: 3785354
    [No Abstract]   [Full Text] [Related]  

  • 4. Transcription of the dystrophin gene in human muscle and non-muscle tissue.
    Chelly J; Kaplan JC; Maire P; Gautron S; Kahn A
    Nature; 1988 Jun; 333(6176):858-60. PubMed ID: 3290682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothesis: the existence of embryonic and adult isoforms of mRNA dystrophin provides an explanation for unusual clinical findings.
    Zatz M; Passos-Bueno MR; Vainzof M; Pavanello RC
    Am J Med Genet; 1989 Mar; 32(3):438-41. PubMed ID: 2658593
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue-specific isoforms of dystrophin.
    Walsh FS; Pizzey JA; Dickson G
    Trends Neurosci; 1989 Jul; 12(7):235-8. PubMed ID: 2475931
    [No Abstract]   [Full Text] [Related]  

  • 7. [Structural proteins of the opaque muscle fibers in Duchenne muscular dystrophy].
    Uchino M; Araki S; Yoshida O; Uekawa K
    Rinsho Shinkeigaku; 1985 Feb; 25(2):166-70. PubMed ID: 4017351
    [No Abstract]   [Full Text] [Related]  

  • 8. [Muscle structural proteins of the opaque fibers in Duchenne type muscular dystrophy].
    Uchino M; Araki S; Yoshida O; Uekawa K
    Rinsho Shinkeigaku; 1983 Aug; 23(8):706-10. PubMed ID: 6661873
    [No Abstract]   [Full Text] [Related]  

  • 9. Dystrophin. The gene and its product.
    Mandel JL
    Nature; 1989 Jun; 339(6226):584-6. PubMed ID: 2660004
    [No Abstract]   [Full Text] [Related]  

  • 10. Dysferlin and the plasma membrane repair in muscular dystrophy.
    Bansal D; Campbell KP
    Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duchenne muscular dystrophy. Localizing the gene product.
    Beam KG
    Nature; 1988 Jun; 333(6176):798-9. PubMed ID: 3290681
    [No Abstract]   [Full Text] [Related]  

  • 12. Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice.
    Greenberg DS; Sunada Y; Campbell KP; Yaffe D; Nudel U
    Nat Genet; 1994 Dec; 8(4):340-4. PubMed ID: 7894483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of Becker muscular dystrophy resulting from the skipping of four contiguous exons (71-74) of the dystrophin gene during mRNA maturation.
    Patria SY; Alimsardjono H; Nishio H; Takeshima Y; Nakamura H; Matsuo M
    Proc Assoc Am Physicians; 1996 Jul; 108(4):308-14. PubMed ID: 8863344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin.
    Cox GA; Phelps SF; Chapman VM; Chamberlain JS
    Nat Genet; 1993 May; 4(1):87-93. PubMed ID: 8099842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
    Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
    Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient page. Gene therapy and muscular dystrophies.
    Karceski S
    Neurology; 2008 Jul; 71(4):e6-8. PubMed ID: 18645160
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide.
    Arahata K; Ishiura S; Ishiguro T; Tsukahara T; Suhara Y; Eguchi C; Ishihara T; Nonaka I; Ozawa E; Sugita H
    Nature; 1988 Jun; 333(6176):861-3. PubMed ID: 3290683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunolocalisation of dystrophin in the immature human neurons and muscles.
    Mussini I; Sogos V; Della Barbera M; Ennas MG; Gremo F
    Ital J Anat Embryol; 1995; 100 Suppl 1():155-63. PubMed ID: 11322288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystrophin under scrutiny.
    Oexle K; Schliwa M
    Biol Cell; 1989; 67(3):239-41. PubMed ID: 2695190
    [No Abstract]   [Full Text] [Related]  

  • 20. Sequential expression of genes involved in muscular dystrophies during human development.
    Durand M; Suel L; Barbet JP; Beckmann JS; Fougerousse F
    Morphologie; 2002 Jun; 86(273):9-12. PubMed ID: 12224393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.